title: Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.
abstract: OBJECTIVE
  Activation of phospholipase Cγ1 (PLCγ1) by vascular endothelial growth factor receptor (VEGFR)-2 is necessary for proliferation and tube formation of endothelial cells in vitro. Previous work has demonstrated that Casitas B-lineage lymphoma (c-Cbl) promotes ubiquitination of PLCγ1 and suppression of its tyrosine phosphorylation. This study was designed to evaluate the importance of PLCγ1 and c-Cbl in experimental choroidal neovascularization (CNV).
  
  
  METHODS
  The role of PLCγ1 was studied in three models of angiogenesis: the endothelial cell culture system, the chorioallantoic membrane (CAM) assay, and the laser-induced CNV model. Endothelial cells were analyzed for the role of PLCγ1 in promoting tube formation. CAMs were incubated with pharmacologic agents that either inhibit or stimulate PLCγ1. CNV was induced in wild-type and c-Cbl-knockout mice, and the progression of CNV was evaluated by fluorescein angiography.
  
  
  RESULTS
  Activation of PLCγ1 was necessary for tube formation of endothelial cells. PLCγ1 stimulation increased the growth of blood vessels and conversely, PLCγ1 inhibition decreased the growth of blood vessels in the CAM model. CNV lesions in the c-Cbl-knockout mice were significantly greater in number, more confluent, and increased in size with time, compared with those in the control wild-type mice.
  
  
  CONCLUSIONS
  The data show that PLCγ1 plays an important role in angiogenesis. Loss of c-Cbl results in enhanced CNV in the eye. The study also shows that c-Cbl plays an important role in ocular angiogenesis, suggesting that modulation of c-Cbl activity or inhibition of PLCγ1 would be a compelling target for antiangiogenesis therapy.
authors.affiliation: Department of Ophthalmology, Boston University School of Medicine, Boston, MA 02114, USA. deeba.husain@bmc.org
authors.forename: Deeba
authors.initials: D
authors.lastname: Husain
authors.forename: Rosana D
authors.initials: RD
authors.lastname: Meyer
authors.forename: Manisha
authors.initials: M
authors.lastname: Mehta
authors.forename: Walther M
authors.initials: WM
authors.lastname: Pfeifer
authors.forename: Eva
authors.initials: E
authors.lastname: Chou
authors.forename: Gregory
authors.initials: G
authors.lastname: Navruzbekov
authors.forename: Ednan
authors.initials: E
authors.lastname: Ahmed
authors.forename: Nader
authors.initials: N
authors.lastname: Rahimi
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000166:cytology; D001808:Blood Vessels / Q000502:physiology; D015153:Blotting, Western; D002478:Cells, Cultured; D002642:Chick Embryo; D049033:Chorioallantoic Membrane / Q000098:blood supply; D020256:Choroidal Neovascularization / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000378:metabolism; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005451:Fluorescein Angiography; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D051966:Phospholipase C gamma / Q000037:antagonists & inhibitors / Q000378:metabolism*; D050721:Proto-Oncogene Proteins c-cbl / Q000502:physiology*; D013552:Swine; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D050721:Proto-Oncogene Proteins c-cbl; D040301:Vascular Endothelial Growth Factor Receptor-2; D051966:Phospholipase C gamma; C493849:Cbl protein, mouse